pharmaceutical-investing Inovio Closes License and Collaboration Agreement with ApolloBio To Develop and Commercialize VGX-3100 in Greater China
pharmaceutical-investing Dova Pharmaceuticals Signs Exclusive Distribution Agreement with Fosun Pharma For Mainland China and Hong Kong
pharmaceutical-investing Tetraphase Pharmaceuticals Enters into Exclusive Development and Commercialization Agreement with Everest Medicines
pharmaceutical-investing Amarin Announces Commencement of VASCEPA® Clinical Development in Mainland China
medical-device-investing CVR Medical Enters China, Executes Preliminary LOI To Launch Its CSS Device In World’s Largest Market
Rakovina Therapeutics Announces Corporate Update Including up to $1.5 Million in New Financing, Leadership Appointments and Debt Restructuring
